STOCK TITAN

Nektar to Announce Financial Results for the Second Quarter 2022 on Thursday, August 4, 2022, After Close of U.S.-Based Financial Markets

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Nektar Therapeutics (NASDAQ: NKTR) will announce its Q2 financial results on August 4, 2022, post U.S. markets close. CEO Howard Robin will host a conference call at 5:00 p.m. ET to discuss results. Access to the press release and the live audio webcast is available through their website. The conference call will also have a replay available until September 4, 2022.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO, July 26, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2022 on Thursday, August 4, 2022, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through September 4, 2022.

To access the conference call, follow these instructions:

Dial: (833) 634-2591 (U.S); (412) 317-6040 (international)

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and inflammatory diseases as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contacts:
For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-second-quarter-2022-on-thursday-august-4-2022-after-close-of-us-based-financial-markets-301593725.html

SOURCE Nektar Therapeutics

FAQ

When will Nektar Therapeutics announce its Q2 2022 financial results?

Nektar Therapeutics will announce its Q2 2022 financial results on August 4, 2022.

What time is the Nektar conference call for Q2 2022 results?

The conference call for Nektar's Q2 2022 results is scheduled for 5:00 p.m. Eastern Time.

How can I access the Nektar Therapeutics conference call?

The conference call can be accessed by dialing (833) 634-2591 for U.S. callers and (412) 317-6040 for international callers.

Will there be a replay of the Nektar Q2 2022 financial results call?

Yes, a replay of the conference call will be available until September 4, 2022.

Nektar Therapeutics

NASDAQ:NKTR

NKTR Rankings

NKTR Latest News

NKTR Stock Data

194.60M
182.54M
1.06%
76.69%
2.84%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAN FRANCISCO